
Retina & Vitreous Diseases
On this page
Get care
Retina and vitreous disease diagnosis and treatment
At UCSF Health, you'll find comprehensive care for diseases of the retina (light-sensitive layer of tissue at the back of your eye) and vitreous (gel-like substance that makes up the middle of your eye). Our expert team includes board-certified ophthalmologists with specialized training in treating vitreoretinal diseases using the latest therapies and surgery.
Retinal and vitreous diseases we diagnose and treat include:
Degenerative retinal diseases, such as retinitis pigmentosa
Diabetic retinopathy
Inflammatory conditions affecting the back of your eye
Macular degeneration
Macular holes
Macular puckers
Retinal detachments
Retina and vitreous disease diagnosis and treatment
At UCSF Health, you'll find comprehensive care for diseases of the retina (light-sensitive layer of tissue at the back of your eye) and vitreous (gel-like substance that makes up the middle of your eye). Our expert team includes board-certified ophthalmologists with specialized training in treating vitreoretinal diseases using the latest therapies and surgery.
Retinal and vitreous diseases we diagnose and treat include:
Degenerative retinal diseases, such as retinitis pigmentosa
Diabetic retinopathy
Inflammatory conditions affecting the back of your eye
Macular degeneration
Macular holes
Macular puckers
Retinal detachments
Get care
Providers

Armin Afshar, MD, MBA
Ocular Oncology • Retina and Vitreous Diseases
Robert B. Bhisitkul, MD, PhD
Retina and Vitreous Diseases
Eugene De Juan Jr., MD
Retina and Vitreous Diseases
Jacque L. Duncan, MD
Retina and Vitreous Diseases • Pediatric Ophthalmology
Recognized expertise

Best in Northern California and No. 10 (tie) in the nation for ophthalmology
Related services
Related conditions & treatments
Conditions
- Diabetic Retinopathy
- Macular Degeneration
- Macular Hole
- Retinal Detachment
- Retinitis Pigmentosa
Clinical trials
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)Opens in a new window
To evaluate the safety and tolerability of a single dose of ACDN-01 when administered to participants with ABCA4-related retinopathy.Retinal Imaging in Patients With Inherited Retinal DegenerationsOpens in a new window
The current study will assess cone spacing twice at baseline and every 6 months for 30 months. The primary outcome will be measured at 24 months.EyeConic: Qualification for Cone-OptogeneticsOpens in a new window
Number of participants with preserved central retinal volume.
Research initiatives
UCSF Department of Ophthalmology ResearchOpens in a new window
The UCSF Department of Ophthalmology and the Francis I. Proctor Foundation for Research in Ophthalmology are dedicated to uncovering the causes and mechanisms of eye diseases, with the goals of fighting vision loss and restoring sight.





